Esperion Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Esperion Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 54% to $116,334,000. The net income raised on -$209,248,000 and profit margin reached -180%. Total operating expenses were $228,630,000.
Profit Margin
| 2014 | 0 | -36.37M | |
|---|---|---|---|
| 2015 | 0 | -49.78M | |
| 2016 | 0 | -74.97M | |
| 2017 | 0 | -166.98M | |
| 2018 | 184.47M | -201.81M | -109.4% |
| 2019 | 148.36M | -109.02M | -73.48% |
| 2020 | 227.54M | -166.18M | -73.04% |
| 2021 | 78.44M | -318.82M | -406.42% |
| 2022 | 75.47M | -287.81M | -381.34% |
| 2023 | 116.33M | -209.24M | -179.87% |
ESPR Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 116.33M | 75.47M | 78.44M | 227.54M | 148.36M | 184.47M | 0 | 0 | 0 | 0 |
Cost of revenue | 43.26M | 26.96M | 14.21M | 2.39M | 175.61M | 0 | 258K | 0 | 236K | 0 |
Gross profit | 73.06M | 48.50M | 64.23M | 225.15M | -27.24M | 184.47M | -258K | 0 | -236K | 0 |
Operating exp. | ||||||||||
Research and development | 86.10M | 118.92M | 105.97M | 146.93M | 175.61M | 171.48M | 147.60M | 57.86M | 29.80M | 25.30M |
Selling and marketing | 15.6M | 11.3M | 13.7M | 19.3M | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 228.63M | 228.00M | 290.96M | 346.55M | 241.46M | 204.58M | 168.98M | 76.15M | 50.04M | 36.22M |
Operating income | -155.56M | -179.50M | -226.73M | -121.39M | -93.10M | -204.58M | -168.98M | -76.15M | -50.04M | -36.22M |
Other income (expenses), net | -53.68M | -54.15M | -42.37M | -22.15M | -4.06M | 2.77M | 1.99M | 1.54M | 256K | -151K |
Income before tax | -209.24M | -233.65M | -269.10M | -143.55M | -97.16M | -201.81M | -166.98M | -74.97M | -49.78M | -36.37M |
Income tax expense | 0 | 54.15M | 49.71M | 22.63M | 11.85M | 2.87M | 2.13M | 1.67M | 1.06M | 229K |
Net income | -209.24M | -287.81M | -318.82M | -166.18M | -109.02M | -201.81M | -166.98M | -74.97M | -49.78M | -36.37M |
Earnings per share | ||||||||||
Basic EPS | -2.03 | -4.33 | -11.03 | -6.05 | -4.02 | -7.54 | -6.98 | -3.33 | -2.26 | -2.22 |
Diluted EPS | -2.03 | -4.33 | -11.03 | -6.05 | -4.02 | -7.54 | -6.98 | -3.33 | -2.26 | -2.22 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |